In mice, blocking heart-to-brain signals improved healing after a heart attack, hinting at new targets for cardiac therapy.

Physical rehabilitation and symptom management still remain the mainstay of treatment for stroke, as clot removal or ...

The prevalence of these brain changes was generally the same between those with and without a recent stroke and there were no apparent sex differences in the results. Dr Zhou said the study also ...

The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, "perispinal" etanercept—injected into the spinal area—is no more effective than ...

Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...

Even patients with acute ischemic stroke who are delayed in getting to the hospital and already have large cerebral infarcts may derive a benefit from endovascular therapy to remove the clot, ...

Factor XIa inhibitor milvexian did not provide meaningful secondary prevention over dual antiplatelet therapy for stroke survivors, the phase II trial AXIOMATIC-SSP found. In patients with recent ...

A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary prevention of stroke in patients with stroke of atherosclerotic origin, but not those ...